Pfizer
PFE
2,443 hedge funds and large institutions have $129B invested in Pfizer in 2020 Q2 according to their latest regulatory filings, with 152 funds opening new positions, 1,065 increasing their positions, 989 reducing their positions, and 123 closing their positions.
24% more first-time investments, than exits
New positions opened: 152 | Existing positions closed: 123
8% more repeat investments, than reductions
Existing positions increased: 1,065 | Existing positions reduced: 989
0% more funds holding
Funds holding: 2,437 → 2,443 (+6)
0.82% less ownership
Funds ownership: 71.75% → 70.93% (-0.82%)
17% less capital inflows, than outflows
Capital inflows: $5.96B | Capital outflows: $7.22B
35% less call options, than puts
Call options by funds: $900M | Put options by funds: $1.39B
36% less funds holding in top 10
Funds holding in top 10: 140 → 89 (-51)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.15B |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$703M |
| 3 |
Nordea Investment Management
Stockholm,
Sweden
|
+$315M |
| 4 |
State Street
Boston,
Massachusetts
|
+$225M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$197M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$505M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
-$317M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$296M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$251M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$196M |
PFE Hedge Fund Activity: Q2 2020 in Review
2,443 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q2 2020, worth a combined $129B — down 0.74% from $130B a quarter earlier.
Buyers outnumbered sellers: 152 funds opened new PFE positions and 123 closed out — a net gain of 29 holders — while 1,065 added to existing stakes and 989 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $1.15B. The largest seller was JP Morgan Chase, cutting an estimated $505M.
- 2,443 institutional investors held Pfizer (PFE) as of Q2 2020, up from 2,437 in Q1 2020.
- Funds reported $129B of Pfizer stock for Q2 2020, down 0.74% quarter-over-quarter.
- 152 funds opened new Pfizer positions in Q2 2020 and 123 closed out, a net change of +29 holders.
- The largest Pfizer buyer in Q2 2020 was Wellington Management Group, an estimated $1.15B added.
- The largest Pfizer seller in Q2 2020 was JP Morgan Chase, an estimated $505M sold.
Based on aggregated 13F filings for Q2 2020.